InsiderTrades

Form 4 for AMD Advanced Micro Devices

Accepted 2021-09-16 00:00:00 ET · period of report 2021-09-14 · accession 0000002488-21-000166 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2021-09-16 2021-09-14 AMD Su Lisa T Pres, CEO, Dir S - Sale+OE $105.72 -125.0K 2.69M -4% -$13.21M
D 2021-09-16 2021-09-14 AMD Su Lisa T Pres, CEO, Dir M - OptEx $2.92 +125.0K 2.82M +5% +$365.0K
D 2021-09-16 2021-09-14 AMD Su Lisa T Pres, CEO, Dir M - OptEx $0.00 -125.0K 1.00M -11% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2021-09-14 S D 34,419 $104.94 2,782,184 D — — (F2) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 4, 2020. (F3) Transaction executed in multiple trades at prices ranging from $104.45 to $105.44 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
2 Common Common Stock 2021-09-14 M A 125,000 $2.92 2,816,603 D — — (F1) The stock option exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 4, 2020.
3 Common Common Stock 2021-09-14 S D 71,739 $105.86 2,710,445 D — — (F2) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 4, 2020. (F4) Transaction executed in multiple trades at prices ranging from $105.45 to $106.44 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
4 Common Common Stock 2021-09-14 S D 18,842 $106.59 2,691,603 D — — (F2) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 4, 2020. (F5) Transaction executed in multiple trades at prices ranging from $106.45 to $106.79 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
5 Derivative Stock Option Grant 2021-09-14 M D 125,000 $0.00 1,003,457 D $2.92 · — to 2022-12-26 125,000 Common Stock (F6) This option vested 33 1/3% on December 26, 2016 and 8 1/3% per quarter over the subsequent eight quarters.